← Leaderboards
Rona Yoffe Sonabend
Baylor College Of Medicine
$45,866
Attributed
$45,866
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $24.8K · FY2009–11$25K$18.8K$12.5K$6.3K$0
'09
'10
'11
Funding mix
By agency
NIH$45,866 · 4
By mechanism
M01$45,866 · 4
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Maria Monica Gramatges$5,640,613
- Lisa Schum Kahalley$10,210,510
- Cliona M Rooney$13,445,584
- Helen E Heslop$25,308,937
- Rubina A Heptulla$4,982,785
Others in their field
Top investigators on “Survivors”
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$129,558,452
- Laurence H Baker · University Of Michigan At Ann Arbor$81,806,264
- Peter C Adamson · National Childhood Cancer Foundation$64,737,902
- Gregory Armstrong · St. Jude Children'S Research Hospital$61,535,149
- Deborah W Bruner · American College Of Radiology$57,347,005
- Daniel F Hanley · Johns Hopkins University$46,668,549
Research focus
SurvivorsNeoadjuvant TherapyLeukemia, Lymphocytic, Acute, L1SourceUnited States National Institutes Of HealthObesityHyperglycemiaLeukemia, Lymphocytic, AcuteMetabolic SyndromeResourcesTexasBaseCancer CenterCessation Of LifeFundingGrantInfectionInsulin ResistanceDiagnosisClinical ResearchCell InjuryBeta CellAdverse OutcomeFailure (Biologic Function)
Grant awards (4)
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT$14,247
M01 · FY2011 · RR · contact PI
INSULIN RESISTANCE AND METABOLIC SYNDROME IN SURVIVORS OF ACUTE LYMPHOCYTIC$3,562
M01 · FY2011 · RR · contact PI
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT$24,798
M01 · FY2010 · RR · contact PI
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT$3,259
M01 · FY2009 · RR · contact PI